 | • レポートコード：MRC2-11QY03343 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血栓予防治療薬のグローバル市場について調査・分析したレポートです。種類別（抗凝固剤、線維素溶解剤、抗血小板治療薬）市場規模、用途別（病院薬局、小売薬局、オンライン薬局、通信販売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血栓予防治療薬の競争状況、市場シェア ・世界の血栓予防治療薬市場：種類別市場規模 2015年-2020年（抗凝固剤、線維素溶解剤、抗血小板治療薬） ・世界の血栓予防治療薬市場：種類別市場規模予測 2021年-2026年（抗凝固剤、線維素溶解剤、抗血小板治療薬） ・世界の血栓予防治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局、通信販売薬局） ・世界の血栓予防治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局、通信販売薬局） ・北米の血栓予防治療薬市場分析：米国、カナダ ・ヨーロッパの血栓予防治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血栓予防治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血栓予防治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血栓予防治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Daiichi Sankyo Company、Janssen Pharmaceutical、Pfizer、Bayer、Boehringer Ingelheim、Bristol- Meyers Squibb、Portola Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Thrombosis is the process of blood clots that form in the artery or veins. In this thrombosis condition, a clot blocks the flow of blood in the affected area and can create serious complications such as myocardial infraction, Strokes atherosclerotic plaque, among others. Deep vein thrombosis is condition clots that occur in leg or pelvis and if the clots broke off and reached to lungs known as pulmonary embolism.
The increase in incidence of venous thromboembolism conditions, the rise in obese population, myocardial infractions, stroke, pulmonary embolism and genetically related disorders are the factors driving the growth of this market over the forecast period. However, due to lack of awareness about venous thromboembolism conditions, side-effects caused due to current drugs are hindering the growth of blood clot prevention over the forecast period.
Market Analysis and Insights: Global Blood Clot Preventive Drugs Market
The global Blood Clot Preventive Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Blood Clot Preventive Drugs Scope and Market Size
Blood Clot Preventive Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blood Clot Preventive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Blood Clot Preventive Drugs market is segmented into
Anticoagulants
Fibrinolytics
Anti-Platelet Drugs
Segment by Application, the Blood Clot Preventive Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Mail Order Pharmacies
Regional and Country-level Analysis
The Blood Clot Preventive Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Blood Clot Preventive Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Blood Clot Preventive Drugs Market Share Analysis
Blood Clot Preventive Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Blood Clot Preventive Drugs business, the date to enter into the Blood Clot Preventive Drugs market, Blood Clot Preventive Drugs product introduction, recent developments, etc.
The major vendors covered:
Daiichi Sankyo Company
Janssen Pharmaceutical
Pfizer
Bayer
Boehringer Ingelheim
Bristol- Meyers Squibb
Portola Pharmaceuticals
…
1 Study Coverage
1.1 Blood Clot Preventive Drugs Product Introduction
1.2 Market Segments
1.3 Key Blood Clot Preventive Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Blood Clot Preventive Drugs Market Size Growth Rate by Type
1.4.2 Anticoagulants
1.4.3 Fibrinolytics
1.4.4 Anti-Platelet Drugs
1.5 Market by Application
1.5.1 Global Blood Clot Preventive Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Mail Order Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Blood Clot Preventive Drugs Market Size, Estimates and Forecasts
2.1.1 Global Blood Clot Preventive Drugs Revenue 2015-2026
2.1.2 Global Blood Clot Preventive Drugs Sales 2015-2026
2.2 Global Blood Clot Preventive Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Blood Clot Preventive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Blood Clot Preventive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Blood Clot Preventive Drugs Competitor Landscape by Players
3.1 Blood Clot Preventive Drugs Sales by Manufacturers
3.1.1 Blood Clot Preventive Drugs Sales by Manufacturers (2015-2020)
3.1.2 Blood Clot Preventive Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Blood Clot Preventive Drugs Revenue by Manufacturers
3.2.1 Blood Clot Preventive Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Blood Clot Preventive Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Blood Clot Preventive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Blood Clot Preventive Drugs Revenue in 2019
3.2.5 Global Blood Clot Preventive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Blood Clot Preventive Drugs Price by Manufacturers
3.4 Blood Clot Preventive Drugs Manufacturing Base Distribution, Product Types
3.4.1 Blood Clot Preventive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Blood Clot Preventive Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Blood Clot Preventive Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Blood Clot Preventive Drugs Market Size by Type (2015-2020)
4.1.1 Global Blood Clot Preventive Drugs Sales by Type (2015-2020)
4.1.2 Global Blood Clot Preventive Drugs Revenue by Type (2015-2020)
4.1.3 Blood Clot Preventive Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Blood Clot Preventive Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Blood Clot Preventive Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Blood Clot Preventive Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Blood Clot Preventive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Blood Clot Preventive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Blood Clot Preventive Drugs Market Size by Application (2015-2020)
5.1.1 Global Blood Clot Preventive Drugs Sales by Application (2015-2020)
5.1.2 Global Blood Clot Preventive Drugs Revenue by Application (2015-2020)
5.1.3 Blood Clot Preventive Drugs Price by Application (2015-2020)
5.2 Blood Clot Preventive Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Blood Clot Preventive Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Blood Clot Preventive Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Blood Clot Preventive Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Blood Clot Preventive Drugs by Country
6.1.1 North America Blood Clot Preventive Drugs Sales by Country
6.1.2 North America Blood Clot Preventive Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Blood Clot Preventive Drugs Market Facts & Figures by Type
6.3 North America Blood Clot Preventive Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Blood Clot Preventive Drugs by Country
7.1.1 Europe Blood Clot Preventive Drugs Sales by Country
7.1.2 Europe Blood Clot Preventive Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Blood Clot Preventive Drugs Market Facts & Figures by Type
7.3 Europe Blood Clot Preventive Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Blood Clot Preventive Drugs by Region
8.1.1 Asia Pacific Blood Clot Preventive Drugs Sales by Region
8.1.2 Asia Pacific Blood Clot Preventive Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Blood Clot Preventive Drugs Market Facts & Figures by Type
8.3 Asia Pacific Blood Clot Preventive Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Blood Clot Preventive Drugs by Country
9.1.1 Latin America Blood Clot Preventive Drugs Sales by Country
9.1.2 Latin America Blood Clot Preventive Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Blood Clot Preventive Drugs Market Facts & Figures by Type
9.3 Central & South America Blood Clot Preventive Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Blood Clot Preventive Drugs by Country
10.1.1 Middle East and Africa Blood Clot Preventive Drugs Sales by Country
10.1.2 Middle East and Africa Blood Clot Preventive Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Blood Clot Preventive Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Blood Clot Preventive Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Corporation Information
11.1.2 Daiichi Sankyo Company Description and Business Overview
11.1.3 Daiichi Sankyo Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Company Blood Clot Preventive Drugs Products Offered
11.1.5 Daiichi Sankyo Company Related Developments
11.2 Janssen Pharmaceutical
11.2.1 Janssen Pharmaceutical Corporation Information
11.2.2 Janssen Pharmaceutical Description and Business Overview
11.2.3 Janssen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Janssen Pharmaceutical Blood Clot Preventive Drugs Products Offered
11.2.5 Janssen Pharmaceutical Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Blood Clot Preventive Drugs Products Offered
11.3.5 Pfizer Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Blood Clot Preventive Drugs Products Offered
11.4.5 Bayer Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Blood Clot Preventive Drugs Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 Bristol- Meyers Squibb
11.6.1 Bristol- Meyers Squibb Corporation Information
11.6.2 Bristol- Meyers Squibb Description and Business Overview
11.6.3 Bristol- Meyers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol- Meyers Squibb Blood Clot Preventive Drugs Products Offered
11.6.5 Bristol- Meyers Squibb Related Developments
11.7 Portola Pharmaceuticals
11.7.1 Portola Pharmaceuticals Corporation Information
11.7.2 Portola Pharmaceuticals Description and Business Overview
11.7.3 Portola Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Portola Pharmaceuticals Blood Clot Preventive Drugs Products Offered
11.7.5 Portola Pharmaceuticals Related Developments
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Corporation Information
11.1.2 Daiichi Sankyo Company Description and Business Overview
11.1.3 Daiichi Sankyo Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Company Blood Clot Preventive Drugs Products Offered
11.1.5 Daiichi Sankyo Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Blood Clot Preventive Drugs Market Estimates and Projections by Region
12.1.1 Global Blood Clot Preventive Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Blood Clot Preventive Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Blood Clot Preventive Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Blood Clot Preventive Drugs Sales Forecast (2021-2026)
12.2.2 North America: Blood Clot Preventive Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Blood Clot Preventive Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Blood Clot Preventive Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Blood Clot Preventive Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Blood Clot Preventive Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Blood Clot Preventive Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Blood Clot Preventive Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Blood Clot Preventive Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Blood Clot Preventive Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Blood Clot Preventive Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Blood Clot Preventive Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Blood Clot Preventive Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Blood Clot Preventive Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Blood Clot Preventive Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Blood Clot Preventive Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Blood Clot Preventive Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Blood Clot Preventive Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Blood Clot Preventive Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Blood Clot Preventive Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Blood Clot Preventive Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Blood Clot Preventive Drugs Market Segments
Table 2. Ranking of Global Top Blood Clot Preventive Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Blood Clot Preventive Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anticoagulants
Table 5. Major Manufacturers of Fibrinolytics
Table 6. Major Manufacturers of Anti-Platelet Drugs
Table 7. Global Blood Clot Preventive Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Blood Clot Preventive Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Blood Clot Preventive Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Blood Clot Preventive Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Blood Clot Preventive Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Blood Clot Preventive Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Blood Clot Preventive Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Blood Clot Preventive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Blood Clot Preventive Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Clot Preventive Drugs as of 2019)
Table 16. Blood Clot Preventive Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Blood Clot Preventive Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Blood Clot Preventive Drugs Price (2015-2020) (USD/Unit)
Table 19. Blood Clot Preventive Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Blood Clot Preventive Drugs Product Type
Table 21. Date of International Manufacturers Enter into Blood Clot Preventive Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Blood Clot Preventive Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Blood Clot Preventive Drugs Sales Share by Type (2015-2020)
Table 25. Global Blood Clot Preventive Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Blood Clot Preventive Drugs Revenue Share by Type (2015-2020)
Table 27. Blood Clot Preventive Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Blood Clot Preventive Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Blood Clot Preventive Drugs Sales Share by Application (2015-2020)
Table 30. North America Blood Clot Preventive Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Blood Clot Preventive Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Blood Clot Preventive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Blood Clot Preventive Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Blood Clot Preventive Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Blood Clot Preventive Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Blood Clot Preventive Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Blood Clot Preventive Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Blood Clot Preventive Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Blood Clot Preventive Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Blood Clot Preventive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Blood Clot Preventive Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Blood Clot Preventive Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Blood Clot Preventive Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Blood Clot Preventive Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Blood Clot Preventive Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Blood Clot Preventive Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Blood Clot Preventive Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Blood Clot Preventive Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Blood Clot Preventive Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Blood Clot Preventive Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Blood Clot Preventive Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Blood Clot Preventive Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Blood Clot Preventive Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Blood Clot Preventive Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Blood Clot Preventive Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Blood Clot Preventive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Blood Clot Preventive Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Blood Clot Preventive Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Blood Clot Preventive Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Blood Clot Preventive Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Blood Clot Preventive Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Blood Clot Preventive Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Blood Clot Preventive Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Blood Clot Preventive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Blood Clot Preventive Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Blood Clot Preventive Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Blood Clot Preventive Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Blood Clot Preventive Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Blood Clot Preventive Drugs Sales Market Share by Application (2015-2020)
Table 70. Daiichi Sankyo Company Corporation Information
Table 71. Daiichi Sankyo Company Description and Major Businesses
Table 72. Daiichi Sankyo Company Blood Clot Preventive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Daiichi Sankyo Company Product
Table 74. Daiichi Sankyo Company Recent Development
Table 75. Janssen Pharmaceutical Corporation Information
Table 76. Janssen Pharmaceutical Description and Major Businesses
Table 77. Janssen Pharmaceutical Blood Clot Preventive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Janssen Pharmaceutical Product
Table 79. Janssen Pharmaceutical Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Blood Clot Preventive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Blood Clot Preventive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Major Businesses
Table 92. Boehringer Ingelheim Blood Clot Preventive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Bristol- Meyers Squibb Corporation Information
Table 96. Bristol- Meyers Squibb Description and Major Businesses
Table 97. Bristol- Meyers Squibb Blood Clot Preventive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bristol- Meyers Squibb Product
Table 99. Bristol- Meyers Squibb Recent Development
Table 100. Portola Pharmaceuticals Corporation Information
Table 101. Portola Pharmaceuticals Description and Major Businesses
Table 102. Portola Pharmaceuticals Blood Clot Preventive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Portola Pharmaceuticals Product
Table 104. Portola Pharmaceuticals Recent Development
Table 105. Global Blood Clot Preventive Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 106. Global Blood Clot Preventive Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Blood Clot Preventive Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Blood Clot Preventive Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Blood Clot Preventive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 110. North America: Blood Clot Preventive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Blood Clot Preventive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 112. Europe: Blood Clot Preventive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Blood Clot Preventive Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 114. Asia Pacific: Blood Clot Preventive Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Blood Clot Preventive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 116. Latin America: Blood Clot Preventive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Blood Clot Preventive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 118. Middle East and Africa: Blood Clot Preventive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Blood Clot Preventive Drugs Players
Table 123. Blood Clot Preventive Drugs Customers List
Table 124. Blood Clot Preventive Drugs Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Clot Preventive Drugs Product Picture
Figure 2. Global Blood Clot Preventive Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Anticoagulants Product Picture
Figure 4. Fibrinolytics Product Picture
Figure 5. Anti-Platelet Drugs Product Picture
Figure 6. Global Blood Clot Preventive Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Mail Order Pharmacies
Figure 11. Blood Clot Preventive Drugs Report Years Considered
Figure 12. Global Blood Clot Preventive Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Blood Clot Preventive Drugs Sales 2015-2026 (K Units)
Figure 14. Global Blood Clot Preventive Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Blood Clot Preventive Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Blood Clot Preventive Drugs Sales Market Share by Region in 2019
Figure 17. Global Blood Clot Preventive Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Blood Clot Preventive Drugs Revenue Market Share by Region in 2019
Figure 19. Global Blood Clot Preventive Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Blood Clot Preventive Drugs Revenue in 2019
Figure 21. Blood Clot Preventive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Blood Clot Preventive Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Blood Clot Preventive Drugs Sales Market Share by Type in 2019
Figure 24. Global Blood Clot Preventive Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Blood Clot Preventive Drugs Revenue Market Share by Type in 2019
Figure 26. Global Blood Clot Preventive Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Blood Clot Preventive Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Blood Clot Preventive Drugs Sales Market Share by Application in 2019
Figure 29. Global Blood Clot Preventive Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Blood Clot Preventive Drugs Revenue Market Share by Application in 2019
Figure 31. North America Blood Clot Preventive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Blood Clot Preventive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Blood Clot Preventive Drugs Sales Market Share by Country in 2019
Figure 34. North America Blood Clot Preventive Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Blood Clot Preventive Drugs Market Share by Type in 2019
Figure 40. North America Blood Clot Preventive Drugs Market Share by Application in 2019
Figure 41. Europe Blood Clot Preventive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Blood Clot Preventive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Blood Clot Preventive Drugs Sales Market Share by Country in 2019
Figure 44. Europe Blood Clot Preventive Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Blood Clot Preventive Drugs Market Share by Type in 2019
Figure 56. Europe Blood Clot Preventive Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Blood Clot Preventive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Blood Clot Preventive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Blood Clot Preventive Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Blood Clot Preventive Drugs Revenue Market Share by Region in 2019
Figure 61. China Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Blood Clot Preventive Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Blood Clot Preventive Drugs Market Share by Application in 2019
Figure 85. Latin America Blood Clot Preventive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Blood Clot Preventive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Blood Clot Preventive Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Blood Clot Preventive Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Blood Clot Preventive Drugs Market Share by Type in 2019
Figure 96. Latin America Blood Clot Preventive Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Blood Clot Preventive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Blood Clot Preventive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Blood Clot Preventive Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Blood Clot Preventive Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Blood Clot Preventive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Blood Clot Preventive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Blood Clot Preventive Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Blood Clot Preventive Drugs Market Share by Application in 2019
Figure 109. North America Blood Clot Preventive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Blood Clot Preventive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Blood Clot Preventive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Blood Clot Preventive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Blood Clot Preventive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Blood Clot Preventive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Blood Clot Preventive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Blood Clot Preventive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Blood Clot Preventive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Blood Clot Preventive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
血液希釈剤の世界市場（～2026年） Market Analysis and Insights: Global Blood-thinning Drugs Market The global Blood-thinning Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Blood-thinning Drugs Scope and Market Size Blood-thinning Drugs market is…- 予防喘息薬の世界市場（～2026年） Drugs for asthma attacks are bronchodilators. The products include pills, potions, inhalers and sprays. The effect is bronchiectasis, which can relieve asthma symptoms quickly and help prevent asthma attacks. This kind of medicine works well and is quite safe. But be careful not to overuse it. The m…
- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…
- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…